MMP9 and glioblastoma: MMP-9 levels and enzymatic activity were elevated in 53.2% (41/77) and 61.0% (47/77) of patients with anti-GBM disease, and in 0% (0/20) and 10% (2/20) of healthy individuals (P < 0.001, P < 0.001, respectively).